CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 3,000 shares at an average $3.19 ($9,580)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 87,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President & COO acquired 73,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 55,000 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market buy Interim CFO bought 3,300 shares at an average $2.85 ($9,389)
- 4 Open-market buy Interim CFO bought 10,000 shares at an average $3.11 ($31,058)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 9 of 49 · 978 filings